Portal:CPTAC/Hallmark/Resisting

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
(replacing mTOR pathway)
Current revision (00:05, 4 December 2018) (view source)
(Added descriptive summary)
 
Line 1: Line 1:
 +
Tumor cells use a variety of strategies to limit or circumvent apoptosis. Most common is the loss of TP53 tumor suppressor function, which eliminates this critical damage sensor from the apoptosis-inducing circuitry. Alternatively, tumors may achieve similar ends by increasing expression of antiapoptotic regulators (Bcl-2, Bcl-xL) or of survival signals (Igf1/2), by downregulating proapoptotic factors (Bax, Bim, Puma), or by short-circuiting the extrinsic ligand-induced death pathway. (Adapted from [https://www.ncbi.nlm.nih.gov/pubmed/21376230 Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011])
*[[Pathway:WP254]] Apoptosis
*[[Pathway:WP254]] Apoptosis
*[[Pathway:WP3982]] miRNA regulation of p53 pathway in prostate cancer
*[[Pathway:WP3982]] miRNA regulation of p53 pathway in prostate cancer

Current revision

Tumor cells use a variety of strategies to limit or circumvent apoptosis. Most common is the loss of TP53 tumor suppressor function, which eliminates this critical damage sensor from the apoptosis-inducing circuitry. Alternatively, tumors may achieve similar ends by increasing expression of antiapoptotic regulators (Bcl-2, Bcl-xL) or of survival signals (Igf1/2), by downregulating proapoptotic factors (Bax, Bim, Puma), or by short-circuiting the extrinsic ligand-induced death pathway. (Adapted from Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011)

Personal tools